0005

Northeast Pharmaceutical Group Co., Ltd. 000597

Market Closed
8 Oct, 06:57
XSHE XSHE
¥
5. 06
+0.12
+2.43%
¥
7.06B Market Cap
- P/E Ratio
0.4% Div Yield
81,464,993 Volume
- Eps
¥ 4.94
Previous Close
Day Range
4.71 5.43
Year Range
3.72 6

000597 Chart

Northeast Pharmaceutical Group Co., Ltd. Profile

Drug Manufacturers—Specialty & Generic Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE0000009G0 ISIN
China Country
6,214 Employees
- Last Dividend
20 May 2020 Last Split
- IPO Date

Overview

Northeast Pharmaceutical Group Co., Ltd. is a substantial enterprise situated in Shenyang, China, founded in 1946. The company operates across various sectors within the pharmaceutical industry, including chemical raw materials, chemical preparations, pharmaceuticals, pharmaceutical engineering, biomedicine, and more. With a firm foundation in China, Northeast Pharmaceutical Group has diversified its business to encompass a broad range of products and services, from vitamin products to in vitro biological diagnostic reagents. Moreover, the company has expanded its operations to include a medical distribution business, positioning itself as a comprehensive provider in the pharmaceutical and healthcare sectors.

Products and Services

The product portfolio of Northeast Pharmaceutical Group Co., Ltd. is extensive, encompassing various health-related fields:

  • Vitamin Products: This includes vitamin C, vitamin B1, vitamin B6, and levocarnitine series, essential for maintaining health and preventing nutrient deficiencies.
  • Anti-infection Products: The company offers a range of antibiotics and treatments, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other related products, addressing various infections.
  • Reproductive System and Sex Hormone Products: These comprise carprost, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets, catering to reproductive health and conditions.
  • Nervous System Products: Including piracetam series, levetiracetam series, vinpocetine, among others, these products are developed to support neurological health and function.
  • Essence and Cannabis-Containing Series Products: Offering morphine hydrochloride injection, pethidine hydrochloride injection, compound codeine phosphate syrup, morphine hydrochloride tablets, and oxycodone hydrochloride injection, focusing on pain management and palliative care.
  • Anti-AIDS Products: Comprising kedu/zidovudine tablets, efavirenz tablets, and others, these products are directed at managing HIV/AIDS.
  • Digestive System Products: Including bacillus licheniformis, aluminum magnesium carbonate chewable tablets, among others, addressing various digestive system conditions.
  • In Vitro Biological Diagnostic Reagent Products: Such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. These are critical for the detection and management of these diseases through laboratory tests.
  • General Health Products: Offering chondroitin ammonia sulfate collagen D3 calcium capsules, protein powder, and probiotic powder, which are geared towards overall health and well-being.
  • Additional Pharmaceuticals: The company also manufactures a wide assortment of other drugs, including amlodipine maleate, narcotine syrup, xiaoke citridin tablets, acetaminophen tablets, qutong tablets, metronidazole tablets, tinidazole tablets, and amphenamine tablets, covering a wide range of therapeutic areas.
  • Specialized Medicine Series: Covering obstetrics and gynecology system, urinary system, antiviral, cardiovascular and cerebrovascular, analgesic and analgesic, and biological diagnosis series medicines, Northeast Pharmaceutical Group Co., Ltd. addresses specific medical needs across various fields.

In addition to its extensive product lineup, the company is actively involved in the medical distribution business, enhancing its role in the pharmaceutical and healthcare ecosystem.

Contact Information

Address: No. 8, Kunming Lake Street
Phone: 86 24 2580 6963